SS-31 and Kisspeptin-10 represent two functionally distinct classes of synthesized research peptides targeting entirely separate physiological pathways in laboratory models. While SS-31 acts at the subcellular level to stabilize mitochondrial membrane integrity, Kisspeptin-10 functions as a neuroendocrine signal regulating upstream reproductive axis activity.
SS-31 and Kisspeptin-10 represent two functionally distinct classes of synthesized research peptides targeting entirely separate physiological pathways in laboratory models. While SS-31 acts at the subcellular level to stabilize mitochondrial membrane integrity, Kisspeptin-10 functions as a neuroendocrine signal regulating upstream reproductive axis activity.
SS-31 (Elamipretide) is a synthetic tetrapeptide that selectively targets inner mitochondrial membrane cardiolipin to optimize bioenergetics and suppress electron transport chain-derived reactive oxygen species. In contrast, Kisspeptin-10 is a decapeptide that acts as an endogenous agonist for the KISS1R receptor, serving as a primary upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. These compounds serve non-overlapping roles in laboratory research designs.
While researchers evaluating bioenergetics, oxidative stress, and cellular aging frequently select SS-31, investigators analyzing neuroendocrine cascades, gonadotropin-releasing hormone (GnRH) pulse generation, and reproductive axis signaling utilize Kisspeptin-10. Understanding their divergent mechanisms, stability parameters, and receptor dynamics is critical for establishing sound in vitro and in vivo protocols.
To assist laboratory personnel in selecting the appropriate peptide for experimental protocols, the table below provides a side-by-side technical comparison of SS-31 and Kisspeptin-10 across core biochemical and operational metrics.
| Technical Parameter | SS-31 (Elamipretide) | Kisspeptin-10 | | :--- | :--- | :--- | | Primary Molecular Target | Inner Mitochondrial Membrane Cardiolipin | KISS1R (GPR54) Receptor | | Primary Mechanistic Class | Mitoprotective / Antioxidant Tetrapeptide | Reproductive Signaling / Endocrine Peptide | | Sequence / Structure | D-Arg-2'6'-Dmt-Lys-Phe-NH2 | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Tyr-NH2 | | Molecular Weight | ~639.8 g/mol | ~1302.4 g/mol | | Reported In Vivo Half-Life | ~2 to 4 hours (plasma in rodent models) | ~10 to 20 minutes (rapid enzymatic degradation) | | Primary Solubility Medium | Aqueous buffers / Sterile Bacteriostatic Water | Aqueous buffers / Dilute DMSO (if aggregation occurs) | | Preclinical Model Focus | Mitochondrial decay, ischemia-reperfusion, ROS models | Neuroendocrine regulation, GnRH pulse signaling, HPG axis | | Laboratory Standard Packaging | 10mg, 50mg lyophilized vials | 5mg, 10mg lyophilized vials |
Investigators requiring raw material verification prior to inventory selection can examine our complete directory of catalog compounds via the all peptides catalog.
SS-31 is a water-soluble, aromatic-cationic tetrapeptide designed to selectively penetrate cell membranes and concentrate within the inner mitochondrial membrane (IMM). The peptide features an alternating aromatic-basic amino acid sequence that enables electrostatic interactions with cardiolipin, a unique phospholipid polyglycerol phospholipid residing almost exclusively within the IMM.
Under physiological conditions, cardiolipin regulates electron transfer by maintaining structural curvature and organizing respiratory chain complexes into functional supercomplexes (respirasomes). In preclinical models of cellular stress or aging, cardiolipin undergoes peroxidation, destabilizing cristae structure and inducing electron leakage. Preclinical research demonstrates that SS-31 binds selectively to cardiolipin through hydrophobic and electrostatic forces, preventing cardiolipin peroxidation, stabilizing electron transport chain complexes (specifically Complexes I and IV), and preserving ATP generation capacity without disrupting normal resting membrane potential.
Kisspeptin-10 represents the minimal active C-terminal decapeptide fragment derived from the precursor Kisspeptin-1 (KISS1) gene product. It possesses a conserved C-terminal RF-amide motif that is necessary and sufficient for full activation of the G-protein coupled receptor KISS1R (formerly designated GPR54).
As a fundamental reproductive signaling peptide, Kisspeptin-10 is studied primarily for its role as an upstream regulator of the reproductive hormone axis. Upon binding to KISS1R located on GnRH neurons within the hypothalamus, Kisspeptin-10 activates intracellular phospholipase C (PLC) and inositol trisphosphate ($IP_3$) signaling cascades. This event triggers intracellular calcium mobilization, resulting in the depolarization of GnRH neurons and the pulsed secretion of GnRH into the hypophyseal portal system. Consequently, downstream pituitary release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) is initiated in animal models.
In animal literature, SS-31 has been widely evaluated in rodent models of ischemia-reperfusion injury, acute kidney injury, and neurodegenerative decline. Research indicates that administration of SS-31 in murine models preserves structural cristae morphology, reduces mitochondrial ROS production, and mitigates apoptosis triggered by cytochrome c release. Furthermore, in vitro assays involving isolated mitochondria demonstrate that SS-31 improves respiratory control ratios (RCR) under oxidative stress conditions.
Conversely, Kisspeptin-10 literature centers on central nervous system microinfusion, hypothalamic slice cultures, and endocrine profiling assays. Animal models demonstrate that central or peripheral administration of Kisspeptin-10 induces rapid, dose-dependent spikes in plasma LH and FSH levels. Studies evaluating pubertal onset, hypogonadotropic conditions, and seasonal breeding regulation utilize Kisspeptin-10 to dissect the precise feedback loops governing the HPG axis, demonstrating its pivotal status in neuroendocrine physiology.
The pharmacokinetic behavior of these compounds differs substantially based on molecular structure and degradation pathways. SS-31 incorporates synthetic D-amino acids (such as D-arginine) and modified residues (such as 2'6'-dimethyltyrosine), which significantly increase its resistance to non-specific systemic peptidases. Consequently, SS-31 exhibits an extended systemic half-life of approximately 2 to 4 hours in rodent models, allowing sustained bioenergetic support across acute assays.
In contrast, natural unmodified Kisspeptin-10 consists exclusively of L-amino acids and is rapidly targetable by circulating peptidases, including endopeptidase 24.11 (neprilysin) and prolyl endopeptidase. As a result, the plasma half-life of Kisspeptin-10 in preclinical animal models is extremely brief, typically measured between 10 and 20 minutes. Researchers designing longitudinal endocrine protocols often utilize continuous micro-infusion pumps or chemical modifications when extended receptor engagement is required in experimental models.
Both compounds are supplied as highly purified, lyophilized powders to ensure long-term stability prior to reconstitutive laboratory setup. To maintain structural stability, lyophilized vials should be stored at -20°C or -80°C in desiccated environments, away from direct light.
Reconstitution protocols require careful selection of solvents based on target assays. SS-31 readily dissolves in sterile 0.9% sodium chloride or phosphate-buffered saline (PBS) due to its strongly hydrophilic basic residues. Kisspeptin-10 generally dissolves well in sterile water or PBS; however, high concentration preparations may benefit from initial dissolution in a small volume of 0.1% acetic acid or sterile DMSO prior to aqueous buffer dilution to prevent hydrophobic aggregation.
To calculate precise concentrations and stock dilutions for micro-pipetting, researchers should consult our interactive reconstitution calculator. Furthermore, lot-specific analytical verification, purity metrics, and mass spectra can be confirmed via our dedicated certificate of analysis portal.
Choosing between SS-31 and Kisspeptin-10 depends entirely on the primary scientific endpoints established in the experimental design:
- **Select SS-31** if your study investigates cellular energetics, mitochondrial membrane dynamics, electron transport chain efficiency, oxidative stress suppression, or organ failure models driven by microvascular or bioenergetic collapse.
- **Select Kisspeptin-10** if your protocol centers on reproductive physiology, hypothalamic neural networks, upstream regulation of the reproductive hormone axis, GnRH neuronal activation, or gonadotropin secretion patterns.
Because these compounds engage entirely independent pathways, they are rarely interchangeable, though certain interdisciplinary models examining metabolic control of fertility may examine both compounds in parallel arms.
When designing comparative or multi-arm research studies, investigators frequently evaluate related research peptides within the same biological domains. For bioenergetic and mitochondrial research, alternative targets include MOTS-c, a mitochondrial-derived peptide involved in metabolic homeostasis, alongside SS-31 for membrane preservation. Conversely, researchers focusing on neuroendocrine and reproductive signaling cascades often contrast Kisspeptin-10 against downstream axis modulation tools like Triptorelin or GnRH analogs. Exploring these secondary targets provides a broader contextual framework when mapping complex endocrine or metabolic pathways.
PX1 Research maintains rigorous quality standards to ensure consistency, purity, and reproducibility across all experimental workflows. Every batch of synthesized peptide undergoes comprehensive High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis to confirm sequence accuracy and guarantee purity levels exceeding 98%.
All products are USA-manufactured in GMP-compliant facilities and tested by independent ISO 17025 accredited laboratories. Vials are subjected to stringent endotoxin testing to verify suitability for sensitive in vitro assays and animal model protocols. Orders ship directly from our state-of-the-art facilities in California and Arizona, offering same-day dispatch for orders finalized prior to cutoff times. Institutional accounts and high-volume laboratory facilities can access dedicated fulfillment terms through our wholesale inquiry program.
What is the primary difference in biological target between SS-31 and Kisspeptin-10?
SS-31 selectively targets cardiolipin within the inner mitochondrial membrane to optimize bioenergetics and reduce oxidative stress. Kisspeptin-10 is a cell-surface receptor agonist that selectively activates the G-protein coupled receptor KISS1R (GPR54) on GnRH neurons.
What is the primary research application of Kisspeptin-10?
Kisspeptin-10 is researched for the upstream regulation of the reproductive hormone (HPG) axis, focusing on GnRH neuronal excitation, LH/FSH surge induction, and neuroendocrine feedback mechanisms.
How do the half-lives of SS-31 and Kisspeptin-10 compare in preclinical models?
SS-31 features modified synthetic amino acids that yield a plasma half-life of approximately 2 to 4 hours in rodents. Unmodified Kisspeptin-10 is rapidly cleaved by plasma endopeptidases, resulting in a short half-life of 10 to 20 minutes.
Can Kisspeptin-10 and SS-31 be reconstituted in the same solvent?
Both peptides can typically be reconstituted in sterile aqueous buffers such as PBS or sterile water. However, Kisspeptin-10 may require initial solubilization in dilute acetic acid or DMSO if hydrophobic self-aggregation occurs at high stock concentrations.
Where can I inspect third-party testing metrics for PX1 Research compounds?
PX1 Research posts lot-specific Certificates of Analysis (COAs) featuring HPLC and MS data, which can be reviewed directly on our COA portal.
Are SS-31 or Kisspeptin-10 suitable for human clinical or therapeutic application?
No. All compounds provided by PX1 Research are strictly intended for laboratory research use, in vitro assays, and animal model studies. They are not cleared or intended for human consumption, therapeutic use, or veterinary administration.
What endotoxin standards are applied to PX1 peptides?
PX1 Research subjects all peptide lots to formal endotoxin testing via LAL assays to ensure raw material parameters comply with stringent analytical standards required for sensitive cellular research.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.